Forian Analyst Ratings
Roth MKM Maintains Forian(FORA.US) With Buy Rating, Maintains Target Price $5
Forian (FORA) Receives a Buy From Roth MKM
Roth MKM Maintains Forian(FORA.US) With Buy Rating, Maintains Target Price $5
Forian (FORA) Receives a Buy From Roth MKM
VerticalScope Holdings Analyst Ratings
Forian Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)
Lake Street Sticks to Its Buy Rating for Forian (FORA)
VerticalScope Holdings Analyst Ratings
VerticalScope Holdings Analyst Ratings
Roth MKM Initiates Coverage On Forian With Buy Rating, Announces Price Target of $5
Forian Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Mirati Therapeutics (MRTX) and Forian (FORA)
VerticalScope Holdings Analyst Ratings
Lake Street Sticks to Its Buy Rating for Forian (FORA)
Forian (FORA) Gets a Buy From Lake Street
Lake Street Maintains Buy on Forian, Lowers Price Target to $5
Forian Analyst Ratings
Lake Street Reaffirms Their Buy Rating on Forian (FORA)